Tarrytown Expocare’s Acquisition Of Long’s Drugs And Adler’s Pharmacy

Troutman Pepper Hamilton Sanders LLP advised Sheridan Capital Partners and Tarrytown Expocare on the deal.

Tarrytown Expocare (“Tarrytown” or “The Company”), a portfolio company of Sheridan Capital Partners, announced the completed acquisitions of Long’s Drugs, located in Thomson, Georgia, Long’s Closed-Door Pharmacy, located in Columbia, South Carolina, and Adler’s Pharmacy LTC, located in Cherry Hill, NJ. These acquisitions are the latest completed by Tarrytown as the Company continues expanding into new states in order to provide quality care to the Intellectually and Developmentally Disabled populations. The Company now serves individuals in 13 states.

Tarrytown Expocare (“Tarrytown”) is a national long-term care pharmacy that serves individuals with intellectual and developmental disabilities (“IDD”). The Company provides prescription medication to IDD patients primarily residing in group homes and offers clinical administrative services to its facility partners. Tarrytown was founded by Mark Newberry in 2013 and is headquartered in Austin, TX.

Sheridan Capital Partners is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada. Sheridan partners with companies in the verticals of providers and provider services, healthcare IT and outsourced services, and consumer health and medical products, bringing strategic resources to accelerate growth, build enduring value, and achieve strong results.

The Troutman Pepper team was led by John Jones (Picture), James Saling, Yale Bohn and Joe Harrington.

Involved fees earner: Yale Bohn – Troutman Sanders; Joseph Harrington – Troutman Sanders; Joseph Harrington – Troutman Sanders; John Jones – Troutman Sanders; James Saling – Troutman Sanders;

Law Firms: Troutman Sanders;

Clients: Sheridan Capital Partners LLC; Tarrytown Expocare;

Author: Ambrogio Visconti